Ergoteles LLC Volitionrx LTD Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$2.41 - $3.24 $38,314 - $51,509
-15,898 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$3.02 - $4.13 $356,970 - $488,174
-118,202 Reduced 88.14%
15,898 $50,000
Q3 2021

Nov 15, 2021
SELL
$2.98 - $3.48 $2,682 - $3,132
-900 Reduced 0.67%
134,100 $416,000
Q2 2021

Aug 12, 2021
BUY
$3.01 - $3.78 $406,350 - $510,300
135,000 New
135,000 $444,000

Others Institutions Holding VNRX

# of Institutions
27
Shares Held
7.96M
Call Options Held
39K
Put Options Held
0
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email